Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Join | Sign in
Home>Videos>This Video
  Videos

Return

Not happy with your ion chromatograph? Switch to Metrohm now and save!
Metrohm AG

Anyone thinking about exchanging his existing IC system should not wait any longer and switch to Metrohm now. Less need for expensive consumables, outstanding warranties and integral, fully automated sample preparation will benefit users with lower running costs, more efficiency, and highly dependable Swiss technology - for routine analysis and research alike. Investing in Metrohm ion chromatography means routine analysis with much less of expensive consumables such as syringe filters and filter caps required. Integral, fully automated sample preparation (inline dilution, inline calibration, inline dialysis) saves time and stress. The most important benefit in terms of saving money is the patented Metrohm anion suppressor module (MSM). Many users of ion chromatography may have grown used to costly replacements of the anion suppressor of their system every six months or even more frequently, not knowing that Metrohm ion chromatographs come with a 10 year suppressor warranty. This feature alone counts for thousands of US dollars saved over the lifetime of any Metrohm IC system. More and equally exclusive warranties such as a 10 year spare part warranty, 5 year software support, and a general 3 year instrument warranty contribute to a package that make Metrohm ion chromatography the better deal.

Request more information
Company product page


Access to this article and other content is for registered users.

Join the Technology Networks Community

  • Access to the latest scientific news, products and research through Technology Networks
  • Upload and share your posters on ePosters
  • View a library of 1,800+ scientific and medical posters
  • A library of 3,000+ scientific videos on LabTube


Sign In



Forgotten your details? Click Here
If you already have an account with Technology Networks, please use your existing login details. If you do not yet have an account please join here.

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Label-Free Binding Analysis Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
Microchip Captures Clusters of Circulating Tumor Cells
Researchers have developed a microfluidic chip that can capture rare clusters of circulating tumor cells, which could yield important new insights into how cancer spreads.
New Method For Measuring The Concentration Of Medicines In The Blood
Researchers at EPFL have come up with a quick and portable new device for measuring the amount of medicinal drugs in blood.
Alternate Administration Routes for Psychotropic Drugs Reviewed
A review in the Annals of Pharmacotherapy has examined the literature on alternative routes of administration for antipsychotic and antidepressant medications.
Promising Results of Phase 1/2 Trial of Rociletinib in EGFR Lung Cancer Published
Results have been published of a multi-center phase I/II study of the investigational anti-cancer agent rociletinib in patients with EGFR-mutant non-small cell lung cancer (NSCLC) that had progressed after previous treatment with EGFR inhibitors.
Epilepsy Drug Metabolism Test Launched for Epilepsy and Seizure Disorders
Courtagen Life Sciences, Inc have announced the release of a NGS test focused on detection of anti-epileptic drug (AED) compatibilities and interactions for patients receiving treatment for epilepsy or other seizure disorders.
Supercooling May Aid Drug Delivery
A new study published is the first to break down the rules governing the complex process of crystallization through rapid-cooling.
Quotient Clinical Completes Innovative First-In-Human Program
First-in-human clinical program designed to develop an optimal oral formulation.
Neuropsychiatric Drug Candidate Shows Good Safety & Tolerability
Transition Therapeutics announces results from Phase 1 AME & renal clearance clinical studies of neuropsychiatric drug candidate ELND005.
IUPUI Chemist Earns Grant to Improve Drug Screening in Forensics
$273,826 award to improve the speed and accuracy of mass spectrometry for detecting drugs and poisons.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters